8-K: Flexible Solutions International Reports Q2 2026 Results

Flexible Solutions International announced a 14% decrease in Q2 2026 sales to $7.61 million and a net loss of $1.91 million, compared to a net income of $2.03 million in the prior year, citing scaling costs and a prior year R&D payment.

Summary

• Flexible Solutions International (FSI) reported second quarter 2026 sales of $7,610,148, a 14% decrease from $8,867,132 in the second quarter of 2025.
• The company incurred a net loss of $1,912,967, or ($0.15) per share, for Q2 2026, a significant shift from a net income of $2,028,912, or $0.16 per share, in Q2 2025.
• Management attributes the current quarter's financial performance to the costs associated with scaling food-grade contracts and the Panama plant, with revenues from these initiatives not yet fully realized.
• The company anticipates a return to profitability in Q3 2026, with projected revenues exceeding $3 million for the Panama division, over $5 million for the ENP division, and over $4 million for the NanoChem division.
• FSI is focusing its NanoChem division on food-grade products, aiming for over $50 million in annual revenue from two major food contracts within the next 4-6 quarters.
• The company is confident in its ability to execute its plans with existing capital and without resorting to equity actions.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a negative sentiment due to a significant year-over-year decline in revenue and a shift from net income to a net loss, despite management's optimistic outlook for future quarters.

Positives

• The company expects the Panama division to contribute $3 million in revenue in Q3 2026.
• The ENP division is projected to exceed $5 million in revenue for the upcoming quarter (Q3 2026).
• The NanoChem division is expected to scale food product contracts, with revenue exceeding $4 million in Q3 2026.
• Two major food-grade contracts in the NanoChem division have the potential to reach estimated maximum revenues of greater than $50 million per year within 4-6 quarters.
• The company has regained perpetual, exclusive rights to 4 agricultural products and their IP in South America, Central America, and the Caribbean.
• The company is confident in its ability to execute plans with existing capital and without equity actions.

Negatives

• Sales for Q2 2026 decreased by 14% to $7,610,148 compared to $8,867,132 in Q2 2025.
• The company reported a net loss of $1,912,967 ($0.15 per share) in Q2 2026, a significant decline from a net income of $2,028,912 ($0.16 per share) in Q2 2025.
• Scaling costs for food-grade contracts and the Panama plant negatively impacted Q2 profits.
• The Q2 2025 period included $2.5 million in irregular revenue from R&D activity that did not recur in 2026.
• The ENP division experienced a very weak Q2 2026, and agricultural products in the US remain under extreme pressure.
• Raw material prices are unstable and increasing due to oil prices, potentially requiring price increases to customers.

Risks

• The costs of scaling food-grade contracts and the Panama plant are impacting current profitability, with revenues lagging behind these costs.
• The ENP division experienced a weak Q2 2026, and the broader US agricultural market faces extreme pressure from low crop prices, high costs, and uncertainty.
• Shipping prices are unstable and shipping times are longer than usual due to the Iran war.
• Raw material prices are unstable and increasing due to oil prices, which may necessitate price increases to customers in Q3 or Q4.
• Future customers for the food division will be selected to increase average margins, implying current margins are lower than desired.
• The company's ability to achieve projected revenues for its food contracts depends on customer satisfaction and securing all their business before taking on additional major projects.

Future Outlook

Management anticipates a return to profitability in Q3 2026, with projected revenues of over $3 million for the Panama division, over $5 million for the ENP division, and over $4 million for the NanoChem division. The company aims to grow its two major food contracts to over $50 million in annual revenue within 4-6 quarters.

Management Comments

• "This quarter shows the costs of scaling the food grade contracts while the revenue from scaling is not yet fully evident. It also shows the last of the training and development costs in our Panama plant, again, with the revenue lagging the costs. Also, Q2 is the weakest quarter for our ENP division. Finally, the year earlier period had a $2.5 million R&D payment that was not repeated in this year."
• "We rarely give forward guidance. However, we would like to disclose; that we hope the Panama division will contribute $3 million in revenue in Q3, that we hope that ENP division revenue will exceed $5 million for the coming quarter and hope that, the NanoChem division will continue to scale the food product contracts resulting in NanoChem revenue exceeding $4 million in Q3."
• "Growing these two food contracts to the estimated maximum revenues of greater than $50 million per year is our critical goal for the next 4 6 quarters. We hope to execute this to the customers absolute satisfaction and obtain all their business before taking on additional major projects."
• "We would also like to be clear regarding margins in the food division. In order to obtain such large contracts and in order to negotiate tariff and inflation protection clauses, we have lower margins than we prefer. We hope to be in the 22-25% range before tax."
• "We anticipate a return to profitability in Q3 2026 followed by rapidly increasing profits in Q4."
• "We are confident that we can execute our plans with our existing capital and without resorting to any equity actions."

Industry Context

StockSavvy.ai notes that the company operates in diverse sectors including biodegradable polymers for oil extraction, detergent ingredients, water treatment, crop nutrients, and food/nutrition supplements. The current results reflect challenges in scaling new food-grade operations and the cyclical nature of some of its divisions, alongside broader industry pressures in agriculture due to rising costs and market uncertainty.

Stakeholder Impact

• Shareholders: The shift to a net loss and decreased revenue may negatively impact shareholder value in the short term, though management expresses confidence in future recovery.
• Employees: Scaling costs and plant operations may impact employee workload and resource allocation.
• Customers: Potential price increases for raw materials may be passed on to customers in Q3 or Q4.
• Suppliers: Unstable raw material prices and shipping costs could affect supply chain dynamics.

Next Steps

• Continue scaling food-grade contracts in the NanoChem division.
• Optimize production for the 5-year food contract to ensure profitability.
• Increase production and sales for the Panama division, selling direct to historic FL LLC customers and legacy NanoChem customers.
• Focus on increasing average margins in the food division with future customers.
• Complete the transition of legacy industrial and agriculture products to the Panama plant by the end of 2026.
• Recover lost sales and realize historic revenue from the FL LLC investment in South America, Central America, and the Caribbean.

Key Dates

Recommendation

The company is experiencing a significant downturn in financial performance with a substantial year-over-year decrease in revenue and a shift to a net loss. While management projects a strong recovery in Q3 and Q4 driven by new food contracts and operational improvements, these are forward-looking statements. The current results are concerning, and the reliance on future performance for recovery warrants a cautious 'hold' until tangible improvements are demonstrated.

Keywords

biodegradable polymers, food grade, oil extraction, water treatment, crop nutrient, detergent ingredients, nutraceuticals, thermal poly-aspartic acid